Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2

被引:5
|
作者
Braun, Molly R. R. [1 ]
Martinez, Clarissa I. I. [1 ]
Dora, Emery G. G. [1 ]
Showalter, Laura J. J. [1 ]
Mercedes, Annette R. R. [1 ]
Tucker, Sean N. N. [1 ]
机构
[1] Vaxart Inc, Res & Dev, South San Francisco, CA 94080 USA
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
SARS-CoV-2; omicron; delta; Syrian hamster; adenovirus type 5 (Ad5); variant of concern (VOC); challenge model; INFLUENZA-VIRUS; ORAL VACCINATION; AVIAN INFLUENZA; SECRETORY IGA; NEUTRALIZATION; HEMAGGLUTININ; TRANSMISSION; IMMUNITY; MICE;
D O I
10.3389/fimmu.2023.1086035
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
SARS-CoV-2 variant clades continue to circumvent antibody responses elicited by vaccination or infection. Current parenteral vaccination strategies reduce illness and hospitalization, yet do not significantly protect against infection by the more recent variants. It is thought that mucosal vaccination strategies may better protect against infection by inducing immunity at the sites of infection, blocking viral transmission more effectively, and significantly inhibiting the evolution of new variants of concern (VOCs). In this study, we evaluated the immunogenicity and efficacy of a mucosally-delivered, non-replicating, adenovirus type 5-vectored vaccine that expresses the spike (S) gene of Wuhan (rAd5-S-Wuhan), delta (rAd5-S-delta), or omicron (rAd5-S-omicron) SARS-CoV-2 VOCs. Hamsters were immunized with these vaccines intranasally prior to challenge with omicron or delta variants. Additionally, one group was vaccinated by oral gavage with rAd5-S-Wuhan prior to challenge with the delta variant. Both intranasal and oral administration of rAd5-S-Wuhan generated cross-reactive serum IgG and mucosal IgA to all variant spike and RBD proteins tested. rAd5-S-omicron and rAd5-S-delta additionally elicited cross-reactive antibodies, though rAd5-S-omicron had significantly lower binding antibody levels except against its matched antigens. Two weeks after the final vaccination, hamsters were challenged with a SARS-CoV-2 variant; omicron or delta. Whether matched to the challenge or with rAd5-S-Wuhan, all vaccines protected hamsters from weight loss and lung pathology caused by challenge and significantly reduced viral shedding compared to placebo. Vaccination with rAd5-S-Wuhan provided significant protection, although there was an improved reduction in shedding and disease pathology in groups protected by the matched VOC vaccines. Nevertheless, Wuhan-based vaccination elicited the most cross-reactive antibody responses generally. Overall, heterologous vaccination via mucosal routes may be advantageous for second-generation vaccines.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variants
    Chaudhari, Armi M.
    Joshi, Madhvi
    Kumar, Dinesh
    Patel, Amrutlal
    Lokhande, Kiran Bharat
    Krishnan, Anandi
    Hanack, Katja
    Filipek, Slawomir
    Liepmann, Dorian
    Renugopalakrishnan, Venkatesan
    Paulmurugan, Ramasamy
    Joshi, Chaitanya
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 4501 - 4516
  • [22] Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters
    Shiwa-Sudo, Nozomi
    Sakai, Yusuke
    Iwata-Yoshikawa, Naoko
    Watanabe, Shinji
    Yamada, Souichi
    Kuroda, Yudai
    Yamamoto, Tsukasa
    Shirakura, Masayuki
    Fujisaki, Seiichiro
    Miyazaki, Kaya
    Miura, Hideka
    Nagata, Shiho
    Fukushi, Shuetsu
    Maeda, Ken
    Hasegawa, Hideki
    Suzuki, Tadaki
    Nagata, Noriyo
    JOURNAL OF VIROLOGY, 2023, 97 (01)
  • [23] Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters
    Abdelnabi, Rana
    Boudewijns, Robbert
    Foo, Caroline S.
    Seldeslachts, Laura
    Sanchez-Felipe, Lorena
    Zhang, Xin
    Delang, Leen
    Maes, Piet
    Kaptein, Suzanne J. F.
    Weynand, Birgit
    Vande Velde, Greetje
    Neyts, Johan
    Dallmeier, Kai
    EBIOMEDICINE, 2021, 68
  • [24] SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters
    Mohandas, Sreelekshmy
    Yadav, Pragya Dhruv
    Shete, Anita
    Nyayanit, Dimpal
    Sapkal, Gajanan
    Lole, Kavita
    Gupta, Nivedita
    VIRUSES-BASEL, 2021, 13 (09):
  • [25] COVID-19 severity from Omicron and Delta SARS-CoV-2 variants
    Wrenn, Jesse O.
    Pakala, Suman B.
    Vestal, Grant
    Shilts, Meghan H.
    Brown, Hunter M.
    Bowen, Sara M.
    Strickland, Britton A.
    Williams, Timothy
    Mallal, Simon A.
    Jones, Ian D.
    Schmitz, Jonathan E.
    Self, Wesley H.
    Das, Suman R.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (05) : 832 - 836
  • [26] Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2
    Lee, Richard Kuan-Lin
    Li, Tian-Neng
    Chang, Sui-Yuan
    Chao, Tai-Ling
    Kuo, Chun-Hsien
    Pan, Max Yu-Chen
    Chiou, Yu-Ting
    Liao, Kuan-Ju
    Yang, Yi
    Wu, Yi-Hsuan
    Huang, Chen-Hao
    Juan, Hsueh-Fen
    Hsieh, Hsing-Pang
    Wang, Lily Hui-Ching
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [27] Vaccination compartmental epidemiological models for the delta and omicron SARS-CoV-2 variants
    Cuevas-Maraver, J.
    Kevrekidis, P. G.
    Chen, Q. Y.
    Kevrekidis, G. A.
    Drossinos, Y.
    MATHEMATICAL BIOSCIENCES, 2024, 367
  • [28] Vaccine Effect on Household Transmission of Omicron and Delta SARS-CoV-2 Variants
    Kim, Yong Chan
    Kim, Bongyoung
    Son, Nak-Hoon
    Heo, Namwoo
    Nam, Yooju
    Shin, Areum
    Yang, Andrew Jihoon
    Kim, Min Hyung
    Kyong, Taeyoung
    Kang, Eawha
    Park, Yoon Soo
    Kim, Heejung
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (01)
  • [29] Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2
    Ward, Thomas
    Glaser, Alex
    Overton, Christopher E.
    Carpenter, Bob
    Gent, Nick
    Seale, Anna C.
    EPIDEMIOLOGY & INFECTION, 2022, 151
  • [30] Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
    Servellita, Venice
    Syed, Abdullah M.
    Morris, Mary Kate
    Brazer, Noah
    Saldhi, Prachi
    Garcia-Knight, Miguel
    Sreekumar, Bharath
    Khalid, Mir M.
    Ciling, Alison
    Chen, Pei-Yi
    Kumar, G. Renuka
    Gliwa, Amelia S.
    Nguyen, Jenny
    Sotomayor-Gonzalez, Alicia
    Zhang, Yueyuan
    Frias, Edwin
    Prostko, John
    Hackett, John, Jr.
    Andino, Raul
    Wadford, Debra A.
    Hanson, Carl
    Doudna, Jennifer
    Ott, Melanie
    Chiu, Charles Y.
    CELL, 2022, 185 (09) : 1539 - +